Educ'Avk: Recommendations for the Antivitamin K's Gestion
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00227097|
Recruitment Status : Terminated
First Posted : September 27, 2005
Last Update Posted : July 7, 2006
|Condition or disease||Intervention/treatment|
|AVK Treatment||Behavioral: Education Notebook for anticoagulant treatment|
Standard strategies for the implementation of recommendations are exclusively focused on practitioners. But often they do not appear to be effective (insufficient time accorded per patient, lack of training…).
However some qualitative surveys have shown the benefit of a greater role on the part patient in the process of transmitting recommendations through the practitioner.
In this study, patient education is begun by the angiologist or a pharmacy student under the responsibility of the hospital investigator. Follow-up is realized by the patient’s general practitioner.
More patient involvement in the realization of the recommendations could increase the proportion of practitioners who follow the recommendations and decrease the iatrogenicity of antivitamin K (AVK).
|Study Type :||Observational|
|Enrollment :||300 participants|
|Observational Model:||Defined Population|
|Official Title:||Implication of Patient in the Making Ready of Recommendations for the Antivitamin K's Gestion in Case of Thrombosis Embolic Venous's Illness. Randomised Study for Clinical Validation.|
|Study Start Date :||December 2002|
|Study Completion Date :||December 2004|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00227097
|Cardiovascular Departement - University Hospital of Grenoble - BP 217|
|La tronche, Grenoble Cédex 9, France, 38700|
|Principal Investigator:||Jean-Luc BOSSON||Institut National de la Santé Et de la Recherche Médicale, France|